tiprankstipranks
Trending News
More News >
ANEST IWATA Corp. (JP:6381)
:6381
Japanese Market
Advertisement

ANEST IWATA Corp. (6381) AI Stock Analysis

Compare
0 Followers

Top Page

JP:6381

ANEST IWATA Corp.

(6381)

Rating:74Outperform
Price Target:
¥1,729.00
▲(7.66% Upside)
ANEST IWATA Corp.'s overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth, profitability, and cash flow generation. Technical analysis suggests bullish momentum, although caution is advised due to overbought signals. Valuation metrics are reasonable, providing additional support to the stock's attractiveness.

ANEST IWATA Corp. (6381) vs. iShares MSCI Japan ETF (EWJ)

ANEST IWATA Corp. Business Overview & Revenue Model

Company DescriptionANEST IWATA Corp. is a leading Japanese manufacturer specializing in producing high-quality air compressors, coating equipment, and vacuum pumps. The company serves a wide range of industries, including automotive, industrial machinery, and construction. Known for its innovative technology and commitment to sustainability, ANEST IWATA offers products that enhance productivity and efficiency for businesses worldwide.
How the Company Makes MoneyANEST IWATA Corp. generates revenue primarily through the sale of its air compressors, coating equipment, and vacuum pumps. The company's revenue streams are diversified across various sectors, including automotive, industrial manufacturing, and construction, which require reliable and efficient equipment. Additionally, ANEST IWATA benefits from strong partnerships with distributors and OEMs, expanding its market reach globally. After-sales services and maintenance contracts also contribute to the company's revenue, ensuring continued customer engagement and product lifecycle support.

ANEST IWATA Corp. Financial Statement Overview

Summary
ANEST IWATA Corp. exhibits solid financial health with strong revenue growth and profitability. The company maintains a low debt-to-equity ratio and reports robust cash flow generation, indicating efficient operations and strong financial stability.
Income Statement
85
Very Positive
ANEST IWATA Corp. shows a strong gross profit margin of 46.54% for the most recent year. The net profit margin for the same period is 7.86%, indicating effective cost control. Revenue growth has been consistent, with a 1.85% increase from the previous year. EBIT and EBITDA margins are solid at 10.85% and 18.13%, respectively, highlighting efficient operations and strong earnings before interest, tax, depreciation, and amortization.
Balance Sheet
80
Positive
The company maintains a low debt-to-equity ratio of 0.06, implying low financial leverage and risk. The return on equity stands at 9.13%, reflecting good profitability relative to equity. An equity ratio of 67.70% indicates a strong capital structure, with significant equity financing supporting overall financial stability.
Cash Flow
78
Positive
ANEST IWATA Corp. reports a robust free cash flow growth rate of 53.83% year-over-year, demonstrating efficient cash generation. An operating cash flow to net income ratio of 2.28 signifies strong cash flow from operations relative to net income. The free cash flow to net income ratio is 1.66, indicating healthy cash flow available after capital expenditures.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue54.41B54.41B53.42B48.52B42.34B35.59B
Gross Profit25.32B25.32B24.48B21.34B18.23B14.93B
EBITDA10.39B9.86B10.31B9.23B7.36B5.83B
Net Income4.28B4.28B4.93B4.38B3.54B2.62B
Balance Sheet
Total Assets69.20B69.20B66.14B60.14B55.82B49.46B
Cash, Cash Equivalents and Short-Term Investments21.34B21.34B16.93B14.51B14.32B13.20B
Total Debt2.87B2.87B3.07B2.67B2.42B2.47B
Total Liabilities15.64B15.64B16.07B14.88B15.61B13.32B
Stockholders Equity46.85B46.85B44.16B40.03B35.62B32.24B
Cash Flow
Free Cash Flow0.007.08B4.60B2.16B2.45B3.84B
Operating Cash Flow0.009.75B6.77B4.33B3.89B4.60B
Investing Cash Flow0.00-3.25B-1.26B-3.32B-1.08B-1.07B
Financing Cash Flow0.00-3.93B-3.58B-2.36B-2.10B-1.96B

ANEST IWATA Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1606.00
Price Trends
50DMA
1529.86
Positive
100DMA
1417.80
Positive
200DMA
1355.22
Positive
Market Momentum
MACD
17.72
Positive
RSI
67.32
Neutral
STOCH
63.25
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Positive. The current price of 1606 is above the 20-day moving average (MA) of 1573.90, above the 50-day MA of 1529.86, and above the 200-day MA of 1355.22, indicating a bullish trend. The MACD of 17.72 indicates Positive momentum. The RSI at 67.32 is Neutral, neither overbought nor oversold. The STOCH value of 63.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6381.

ANEST IWATA Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
¥59.44B13.11
2.76%2.79%-14.83%
81
Outperform
¥49.77B13.74
3.45%1.90%36.12%
74
Outperform
¥63.55B15.30
2.80%0.52%-8.88%
71
Outperform
¥56.58B12.03
2.63%-6.68%-11.92%
69
Neutral
¥53.27B12.24
2.54%2.55%1.34%
66
Neutral
¥54.10B22.17
2.89%9.31%-62.88%
64
Neutral
$10.75B15.587.24%2.01%2.80%-14.32%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6381
ANEST IWATA Corp.
1,606.00
401.24
33.30%
JP:6237
Iwaki Co. Ltd.
2,530.00
36.25
1.45%
JP:6333
Teikoku Electric Manufacturing Co., Ltd.
3,230.00
770.45
31.32%
JP:6363
Torishima Pump Mfg.Co., Ltd.
2,083.00
-419.66
-16.77%
JP:6364
HOKUETSU INDUSTRIES CO., LTD.
2,066.00
370.89
21.88%
JP:6517
Denyo Co., Ltd.
2,849.00
564.60
24.72%

ANEST IWATA Corp. Corporate Events

ANEST IWATA Unveils New Medium-Term Business Plan
May 9, 2025

ANEST IWATA Corporation has announced the formulation of a new medium-term business plan covering fiscal years 2026 to 2028. This strategic plan is expected to guide the company’s operations and potentially enhance its market position by aligning its goals with future industry trends and stakeholder expectations.

ANEST IWATA Announces Dividend Distribution for Fiscal Year 2025
May 9, 2025

ANEST IWATA Corporation announced a resolution to distribute dividends of surplus, with a record date of March 31, 2025. The dividend per share is set at 23.00 yen, resulting in a total annual dividend of 45.00 yen per share, a decrease from the previous year’s 49.00 yen. This decision aligns with the company’s policy of maintaining a stable return of profits to shareholders, targeting a consolidated dividend payout ratio of 40%. The payout ratio for this fiscal year is 41.6%, reflecting the company’s commitment to balancing shareholder returns with business performance considerations.

ANEST IWATA Corp. Reports FY2024 Results and Unveils New Business Plan
May 9, 2025

ANEST IWATA Corp. reported a 1.8% increase in net sales for FY2024, driven by a sales recovery in Japan and expanded coating equipment sales in Europe. However, operating profit slightly decreased due to higher overseas expenses and a weaker yen. The company has initiated a new medium-term business plan aiming to boost revenue across all regions, with a focus on air compressors. Despite an expected decline in profit due to rising personnel costs and investments, ANEST IWATA plans to enhance shareholder returns through dividends and share buybacks.

ANEST IWATA Reports FY2024 Financial Results with Strategic Adjustments
May 9, 2025

ANEST IWATA Corporation reported its FY2024 financial results, showing a slight increase in net sales by 1.8% to 54,411 million yen, but a decrease in operating profit by 4.4% and ordinary profit by 10.6%. The company also announced changes in its consolidation scope, including the addition of ANEST IWATA A.I.R. Philippines Inc. and the exclusion of ANEST IWATA Italia S.r.l. Despite challenges, the company maintains a strong equity ratio and plans to increase dividends in FY2025, indicating confidence in future growth.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2025